| Ticker Details |
Alphatec Holdings, Inc.
Alphatec Holdings Inc is a medical technology company. It is engaged in the design, development and promotion of products for the surgical treatment of spine disorders. Its product portfolio includes Biolocs, cervical, interbody, and others.
|
| IPO Date: |
June 2, 2006 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$1.93B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.16 | 3.02%
|
| Avg Daily Range (30 D): |
$0.48 | 2.96%
|
| Avg Daily Range (90 D): |
$0.38 | 2.10%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.4M |
| Avg Daily Volume (30 D): |
3.16M |
| Avg Daily Volume (90 D): |
2.39M |
| Trade Size |
| Avg Trade Size (Sh.): |
96 |
| Avg Trade Size (Sh.) (30 D): |
89 |
| Avg Trade Size (Sh.) (90 D): |
84 |
| Institutional Trades |
| Total Institutional Trades: |
2,752 |
| Avg Institutional Trade: |
$1.9M |
| Avg Institutional Trade (30 D): |
$2.89M |
| Avg Institutional Trade (90 D): |
$2.97M |
| Avg Institutional Trade Volume: |
.15M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.22M |
| Avg Closing Trade (30 D): |
$5.88M |
| Avg Closing Trade (90 D): |
$5.34M |
| Avg Closing Volume: |
174.17K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.04
|
$-.19
|
$-.27
|
|
Diluted EPS
|
$-1.04
|
$-.19
|
$-.27
|
|
Revenue
|
$728.02M
|
$196.5M
|
$185.54M
|
|
Gross Profit
|
$503.99M
|
$137.3M
|
$129.1M
|
|
Net Income / Loss
|
$-154.96M
|
$-28.58M
|
$-41.14M
|
|
Operating Income / Loss
|
$-97.13M
|
$-15.93M
|
$-13.09M
|
|
Cost of Revenue
|
$224.04M
|
$59.2M
|
$56.44M
|
|
Net Cash Flow
|
$74.1M
|
$-1.16M
|
$3.74M
|
|
PE Ratio
|
|
|
|
|
|
|